CompanyDrug

AstraZeneca and Merck’s Lynparza Receives New Approval in China

CompanyDeals

Shandong Luoxin Partners with Shanghai Pharma for Strategic Services

Policy / Regulatory

NHSA Releases Guide on Volume-Based Procurement Drug Equivalents

CompanyDrug

Zelgen Biopharmaceuticals Gains NMPA Approval for Jacktinib Clinical Trial in SLE

CompanyDeals

F-star Therapeutics’ Takeover by Sino Biopharmaceutical Delayed Amid CFIUS Review

CompanyDeals

Shenzhen NeuroPlus Secures Seed Funding for Neuromodulation and Bioelectronic Medicine

Company

Merck KGaA Opens Viral Clearance Lab in Shanghai’s Biologics Testing Center

CompanyDeals

METiS Therapeutics In-Licenses Voronoi’s Pan-RAF Inhibitor Program

Policy / Regulatory

Heilongjiang Launches ‘Longjiang Huiminbao’ Supplementary Health Insurance Scheme

CompanyDeals

Immuno Cure BioTech Acquires Majority Stake in Shanghai Teresa Healthcare

CompanyDrug

Lepu Biotechnology’s MRG003 Receives Orphan Drug Designation from FDA

CompanyDeals

Kamari Pharma Completes $8M Investment from Chinese Fund GIBF2